chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLU3
Symptoms: Headache
Clinical narrative: This case was reported by a pharmacist and described the occurrence of headache in a female subject of unspecified age who was vaccinated with FLUARIX, GlaxoSmithKline.  On an unspecified date the subject received unspecified dose of FLUARIX (unknown).  At an unspecified time after vaccination with FLUARIX, the subject experienced headache.  The subject was treated with sumatriptan succinate (Imitrex).  At the time of reporting the outcome of the event was unspecified.
Sex: U
Vaccine: FLUX
Symptoms: Adverse event
Clinical narrative: This case was reported by a pharmacist and described the occurrence of adverse event in a subject of unspecified age and gender who was vaccinated with influenza virus vaccine (manufacturer unspecified).  On an unspecified date the subject received unspecified dose of influenza virus vaccine (unknown).  At an unspecified time after vaccination with Influenza virus vaccine, the subject experienced adverse event.  The reporter stated that he did not know the specifics of the type of events that were experienced by this subject as a consumer reported to the pharmacist that her co-worker experienced "similar problems" after he or she received a flu vaccine (unknown which manufacturer).  This particular subject had experienced arm soreness at the injection site, arm tenderness at the injection site, arm muscle weakness, especially at night, could not use her arm very well and arm weakness.  Details of this case are found in case number A0709413A.  At the time of reporting the outcome of the unspecified event was unspecified.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Vaccination failure
Clinical narrative: This case was reported by a health professional and described the occurrence of influenza in an unspecified number of subjects age and gender who was vaccinated with influenza virus vaccine (manufacturer unspecified). The reporter stated that she had no specifics on these subjects. On an unspecified date the subject received unspecified dose of influenza virus vaccine (unknown). At an unspecified time after vaccination with Influenza virus vaccine, the subject experienced influenza and vaccination failure. At the time of reporting the outcome of the event was unspecified. This case was assessed as medically serious by GSK. The nurse reported that over the years she had seen subjects develop the flu even after receiving the flu vaccine. The nurse reported that over the years she had seen subjects develop the flu even after receiving the flu vaccine but she had no specifics on these subjects nor which vaccine they received.
Age: 6.0
Sex: M
Vaccine: HEP, IPV, MMR, TDAP, VARCEL
Symptoms: Wrong drug administered
Clinical narrative: NONE; Patient was mistakenly given Tdap instead of DTaP.
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline).  Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; Hep B; manufacturer unspecified given on 9 December 2007; Hep A; manufacturer unspecified given on 9 December 2007.  On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste.  The same day, the subject was later vaccination with Fluarix and experienced accidental overdose.  No other adverse events were reported.  In December 2007, the events were resolved.  Outcome of accidental overdose was not specified.  The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose).  Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally.  There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Drug administered at inappropriate site, Dysgeusia
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with FLUARIX, GlaxoSmithKline.  Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007.  On 9 December 2007 the subject received unspecified dose of FLUARIX (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste.  The same day, the subject was later vaccinated with FLUARIX and experienced accidental overdose.  No other adverse events were reported.  In December 2007, the events were resolved.  Outcome of accidental overdose was not specified.  The healthcare professional considered the events were probably related to vaccination with FLUARIX (causality not provided for accidental overdose).  Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally.  There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration, Wrong drug administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with FLUARIX, GlaxoSmithKline.  Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007.  On 9 December 2007 the subject received unspecified dose of FLUARIX (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste.  The same day, the subject was later vaccinated with FLUARIX and experienced accidental overdose.  No other adverse events were reported.  In December 2007, the events were resolved.  Outcome of accidental overdose was not specified.  The healthcare professional considered the events were probably related to vaccination with FLUARIX (causality not provided for accidental overdose).  Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally.  There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Drug administered at inappropriate site, Dysgeusia
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with FLUARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included diphtheria and tetanus and acellular pertussis vaccine ;manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant ;manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated ;manufacturer unspecified given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Wrong drug administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with FLUARIX, GlaxoSmithKline.  Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007.  On 9 December 2007 the subject received unspecified dose of FLUARIX (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste.  The same day, the subject was later vaccinated with FLUARIX and experienced accidental overdose.  No other adverse events were reported.  In December 2007, the events were resolved.  Outcome of accidental overdose was not specified.  The healthcare professional considered the events were probably related to vaccination with FLUARIX (causality not provided for accidental overdose).  Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally.  There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration, Wrong drug administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline). Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with FLUARIX, GlaxoSmithKline. Previous and/or concurrent vaccination included diphtheria and tetanus toxoids and acellular pertussis vaccine; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of FLUARIX (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with FLUARIX and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with FLUARIX (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration, Wrong drug administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline). Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
Sex: U
Vaccine: FLU3, HEP, HEPA, TDAP
Symptoms: Accidental overdose, Dysgeusia, Incorrect route of drug administration
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange taste in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline).  Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; Hep B; manufacturer unspecified given on 9 December 2007; Hep A; manufacturer unspecified given on 9 December 2007.  On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste.  The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose.  No other adverse events were reported.  In December 2007, the events were resolved.  Outcome of accidental overdose was not specified.  The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose).  Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally.  There were no other adverse events other than "bad taste."
Sex: U
Vaccine: DTAP, FLU3, HEP, HEPA
Symptoms: Accidental overdose, Dysgeusia, Wrong drug administered
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of strange test in an adult subject of unspecified gender who was vaccinated with Fluarix (GlaxoSmithKline). Previous and/or concurrent vaccination included DTaP; manufacturer unspecified given on 9 December 2007; hepatitis B vaccine recombinant; manufacturer unspecified given on 9 December 2007; hepatitis A vaccine inactivated; manufacturer unspecified given on 9 December 2007. On 9 December 2007 the subject received unspecified dose of Fluarix (.5 ml, unknown) intranasally (intramuscular formulation administered by other route) and experienced a funny taste. The same day, the subject was later vaccinated with Fluarix and experienced accidental overdose. No other adverse events were reported. In December 2007, the events were resolved. Outcome of accidental overdose was not specified. The healthcare professional considered the events were probably related to vaccination with Fluarix (causality not provided for accidental overdose). Follow-up information received on 14 January 2008 indicated that the intramuscular formulation of vaccine was mistaken as "Flumist" and administered intranasally. There were no other adverse events other than "bad taste."
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Arm pain x 16 days. Unable to abduct arm. Treated with Naprosyn follow up in 5 days.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Heart rate increased
Clinical narrative: My heart rate doubled for 4 days after inj.  My physical therapist checked my pulse and found this to be true.  I had just had knee replacement surgery.  Felt like I was going to have a heart attack.  Have had occasional rapid heart beat.
Age: 62.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Diarrhoea, Headache, Nausea, Pain
Clinical narrative: Headache, chills, body aches, nausea, vomiting, diarrhea.
Age: 62.0
Sex: F
Vaccine: TDAP
Symptoms: Vomiting
Clinical narrative: Headache, chills, body aches, nausea, vomiting, diarrhea.
Sex: F
Vaccine: FLUX, TDAP, FLU3, TDAP
Symptoms: Asthenia, Gait disturbance, Hypoaesthesia, Injection site erythema, Injection site pain
Clinical narrative: Initial redness, swelling and pain around injection site; left deltoid; Now: left arm numbness and pain; diffuse body pain, weakness, and difficulty walking
Sex: F
Vaccine: FLUX, TDAP, FLU3, TDAP
Symptoms: Injection site swelling, Pain, Pain in extremity, Red blood cell sedimentation rate increased
Clinical narrative: Initial redness, swelling and pain around injection site; left deltoid; Now: left arm numbness and pain; diffuse body pain, weakness, and difficulty walking
Sex: F
Vaccine: FLUX, TDAP, FLU3, TDAP
Symptoms: Chest X-ray, Erythema, Gait disturbance, Hypoaesthesia, Injected limb mobility decreased
Clinical narrative: Initial redness, swelling and pain around injection site; left deltoid; Now: left arm numbness and pain; diffuse body pain, weakness, and difficulty walking
Sex: F
Vaccine: FLUX, TDAP, FLU3, TDAP
Symptoms: Pain, Paraesthesia, Rash
Clinical narrative: Initial redness, swelling and pain around injection site; left deltoid; Now: left arm numbness and pain; diffuse body pain, weakness, and difficulty walking
Age: 47.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Headache, Injection site erythema, Myalgia, Nausea
Clinical narrative: 9:00 p.m. developed dull headache, chills, muscle aches, nauseated, got worse on Wed 3/26/08. Noted site getting worse, and nausea since then. Temp 100.4. Today temp 101.4, c/o headache, nausea. Site small redness at injection site.
Age: 47.0
Sex: F
Vaccine: TDAP
Symptoms: Pyrexia
Clinical narrative: 9:00 p.m. developed dull headache, chills, muscle aches, nauseated, got worse on Wed 3/26/08. Noted site getting worse, and nausea since then. Temp 100.4. Today temp 101.4, c/o headache, nausea. Site small redness at injection site.
Age: 21.0
Sex: U
Vaccine: HPV4
Symptoms: Chills, Pyrexia, Upper respiratory tract infection
Clinical narrative: Patient developed a fever of 103 degrees Monday evening. Patient also complained of upper respiratory symptoms; Injection site is fine. Patient also complained of chills. This was patient's 3rd injection.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Blister, Erythema, Injection site erythema, Local reaction, Skin exfoliation
Clinical narrative: Patient reports local erythema with peeling skin at vaccination site when received #1 HPV on 8/1/07. Patient reports dose #2 HPV on 12/20/07 presented with more involved local reaction. She had "burn type" local reaction - erythema 3" diameter with blistering and peeling that lasted 2 weeks. She reports it was similar to her latex reactions.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Unevaluable event
Clinical narrative: No adverse event
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Erythema, Skin warm
Clinical narrative: Left thigh has 9-10cm diameter oval area of redness with minimal warmth. Right thigh has 8cm. diameter area of redness. He is afebrile. Treated with Cephalexin. Discussed with mother possibility of neomycin allergy
Age: 6.0
Sex: M
Vaccine: DTAP, HEP
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Redness of injection site, swelling; fever 102 degrees; Given Tylenol; applied cold compresses
Age: 6.0
Sex: M
Vaccine: HEPA
Symptoms: Pyrexia, Streptococcal identification test, Urticaria
Clinical narrative: Intermittent urticaria appeared evening after administration. Fever was present before admin. of vaccine. Pt also had a (+) rapid Ag strep test on 3/20/08.
Age: 10.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Left arm red, swollen, no fever. Advised by doc to observe and if more tender, painful to be seen at urgent care
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Oedema peripheral
Clinical narrative: 1 1/2" diameter, red, swelling on right deltoid
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Oedema
Clinical narrative: 6x6 cm circular area erythema and edema with central vesicles.
Age: 65.0
Sex: F
Vaccine: PPV, TD
Symptoms: Erythema, Oedema peripheral, Pain, Skin warm
Clinical narrative: Left arm rising with very large red swollen area - warm to touch and patient reports painful; Patient given course Clindamycin
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Erythema, Injection site swelling, Pain in extremity
Clinical narrative: Pain, swelling, and redness (L) shoulder and upper arm.
Age: 2.0
Sex: M
Vaccine: HEP
Symptoms: Dyskinesia, Oral pain, Pyrexia, Toothache
Clinical narrative: 6:30 pm 3/17/08 fever 103.4. Complained of teeth and mouth hurting. Kept sticking tongue out and grabbing it. Dr. on call recommended Advil - took Advil then slept 11hrs.. Fever 100 in morning. No more c/o. Has continued to improve.
Age: 58.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Patient seen on 21 March 2008 for laceration to finger.  Tdap was ordered by provider and administered on same day as visit.  Was placed on Keflex for laceration.  Patient discovered area at injection site red and swollen on 23 March 2008.  Today 27 March 2008, patient presented to clinic with large erythematous area measuring approximately 20 cm in diameter.  Was warm to touch and patient states very itchy.  Sent patient up to Occupational Health Clinic to be seen by provider for reaction.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Autoimmune thyroiditis, Drug hypersensitivity, Immediate post-injection reaction, Injection site pain, Injection site swelling
Clinical narrative: 12/18/08, received Varciella Vaccine Lot # 0720U on left upper forearm.  Immediately area swelled to size of half dollar and painful to touch. On 1/10/2008 blood work drawn for yearly exam. Normal thyroid TSH/T4. On 1/10/2008, began developing allergies to multiple insulins that was being used to treat type 1 IDDM. (Humulin R, Humalog and Novalog allergies after above Varicella vaccine.) Epi-Pen Jr. prescribed and currently maintaining. Changed rapid acting insulin to Apedria.  On 1/18/2008 blood work drawn for follow up regarding allergies and found TSH 6.01/T4 1.0.  On 2/7/2008, diagnosis of Hashimotos thyroid disease and started on Synthroid po daily, which currently is maintained.  02/15/2008 Vax and medical records recd from PCP showing WCC 12/18/07 with Varicella Vax (Merck 0720U) given.  OV 1/16/2008 due to allergy to insulin. Referred to Allergist.  OV 1/31/2008 due to anti-thyroid and anti-gliadin antibodies. Referred to endocrinologist. DX:  Thyroiditis and Celiac Disease. Referred to immunologist.  4/18/08 MR received from allergy/immunology consult from 1/17-2/14/2008 with DX:  Insulin Hypersensitivity, Recent Hashimoto's Disease and Autoimmune Polyglandular Syndrome. Pt developed possible adverse reaction/allergy/hypersensitivity to insulin injections following Varicella vax.  Insulin injections sites with significant redness, swelling and induration, as well as facial redness. Pt also with recent increase in TSH from 1/10/08 to 1/18/2008.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site discomfort, Mobility decreased, No reaction on previous exposure to drug, Pain in extremity
Clinical narrative: Patient having L arm pain since Dec. after she got her tetanus shot. Pt states her arm never stopped hurting but is slowly getting better. Pt has full mobility of arm with sharp pain with some motions. Pt has been stretching to make it feel betting. This is the pt's first time being seen.  Pt noted two episodes of 'popping' in the area of the injection after which her pain improved in stages.  She now notes restriction in specific movements of her shoulder, specifically full abduction and flexion on the left side.  Some lingering discomfort is still at the site as well.  Pt with prior tetanus injections without side effects.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Flushing, Nausea, Vomiting
Clinical narrative: Pt pale, complains of being flushed, dizzy, wretching and nausea.
Age: 19.0
Sex: M
Vaccine: HEPAB, TDAP
Symptoms: Chills, Headache, Injection site pain, Injection site swelling, Insomnia
Clinical narrative: Onset of symptom began 2 hrs. post-vaccination; headache, mild fever, malaise, swelling and arm pain at injection site. Over the next 28 hours pt. had nausea, vomiting, chills, fever 100 F., insomnia, severe headache and lymphadenopathy in L axilla (side of injection).  Presented to our clinic 48 hrs after injection and was evaluated by our Occupational Medicine Physician; given Rx for Ibuprofen 600 mg. t.i.d. and Phenergan 25 mg. po q 4-6 hrs. and sent home to rest, push fluids. Pt. was vaccinated due to his his employment by a construction co. His vaccination history is unknown.  He was born and raised in another country, unable to obtain records.
Age: 19.0
Sex: M
Vaccine: HEPAB, TDAP
Symptoms: Lymphadenopathy, Malaise, Nausea, Pyrexia, Vomiting
Clinical narrative: Onset of symptom began 2 hrs. post-vaccination; headache, mild fever, malaise, swelling and arm pain at injection site. Over the next 28 hours pt. had nausea, vomiting, chills, fever 100 F., insomnia, severe headache and lymphadenopathy in L axilla (side of injection).  Presented to our clinic 48 hrs after injection and was evaluated by our Occupational Medicine Physician; given Rx for Ibuprofen 600 mg. t.i.d. and Phenergan 25 mg. po q 4-6 hrs. and sent home to rest, push fluids. Pt. was vaccinated due to his his employment by a construction co. His vaccination history is unknown.  He was born and raised in another country, unable to obtain records.
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Dizziness, Immediate post-injection reaction
Clinical narrative: WITHIN SECONDS OF RECEIVING THE HPV VACCINE CHILD GOT LIGHTHEADED AND NEEDED TO LIE DOWN
Age: 72.0
Sex: F
Vaccine: HEPA, IPV, TDAP
Symptoms: Dizziness, Headache, Palpitations, Stomach discomfort
Clinical narrative: Patient calls to say she finished her oral typhoid vaccine on Saturday, 3/22/08. Soon after starting to take it she noted some dizziness, headache and heart palpitations. She also noted upset stomach during course of taking medication. Patient has previous hx of AFIB but this has not troubled her for several years. She contacted both her PCP and her cardiologist who advised her to come in only if palpitations should continue. Patient notes her symptoms have subsided since she finished the vaccine. I advised her that the headache and GI symptoms are certainly possible side effects of Vivotif, but no direct cardiac ADR's are listed for the drug. Advised her to see PCP or go to ER or urgent care if she continues to have palpitations or develops chest pain, or if her headache or GI symptoms do not continue to improve.
Age: 77.0
Sex: F
Vaccine: HEPA, TYP
Symptoms: Dysphagia, Dyspnoea, Fatigue, Nausea, Pharyngolaryngeal pain
Clinical narrative: Patient calls this morning saying she woke up yesterday with a sore throat. She began taking oral typhoid vaccine as directed on 3/5/08 and took doses on 3/7, 3/9 and 3/11. Woke up with the sore throat on 3/11 but reports she has been generally fatigued since she began taking the Vivotif vaccine. She reports she also had a fever of 101 degrees yesterday.  I told patient it is possible this is connected with typhoid but that there also are several bad viral illnesses going around. Counseled patient that if she is having trouble swallowing or breathing, or is having spiking fevers, nausea/vomiting or not getting better after a few days she needs to contact her PCP of if more worrisome symptoms go to ER. Patient expresses understanding.   Had MA call patient on Monday, 3/17. Patient reported she was still having the sore throat with moderating fever and she had scheduled appointment with her PCP.   3/27/08   Note that I left message with patient on Friday 3/21/08 asking her to call us back and tell us how she is doing and report on her visit with her PCP.  Have not heard back from her.
Age: 77.0
Sex: F
Vaccine: HEPA, TYP
Symptoms: Pyrexia, Vomiting
Clinical narrative: Patient calls this morning saying she woke up yesterday with a sore throat. She began taking oral typhoid vaccine as directed on 3/5/08 and took doses on 3/7, 3/9 and 3/11. Woke up with the sore throat on 3/11 but reports she has been generally fatigued since she began taking the Vivotif vaccine. She reports she also had a fever of 101 degrees yesterday.  I told patient it is possible this is connected with typhoid but that there also are several bad viral illnesses going around. Counseled patient that if she is having trouble swallowing or breathing, or is having spiking fevers, nausea/vomiting or not getting better after a few days she needs to contact her PCP of if more worrisome symptoms go to ER. Patient expresses understanding.   Had MA call patient on Monday, 3/17. Patient reported she was still having the sore throat with moderating fever and she had scheduled appointment with her PCP.   3/27/08   Note that I left message with patient on Friday 3/21/08 asking her to call us back and tell us how she is doing and report on her visit with her PCP.  Have not heard back from her.
Age: 0.09
Sex: M
Vaccine: HEP
Symptoms: No adverse reaction
Clinical narrative: No adverse events noted. HepB given 3 days before discharge from NICU.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: According to mother on 3/5/08 evening, patient complained of nausea and was "exhausted".  The next morning, 3/6/08, he complained about a "very bad" headache and "very sore" arm.  Mom administered Ibuprofen on 3/6/06 & 3/7/08 for sypmtoms.  All sypmtoms resolved by 3/9/08. No hives, rashes, breathing difficulties, vomiting, loss of consciousness or swelling occured.  Mom reported to Health Department on 3/27/08.
Age: 76.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Hypokinesia, Injection site pain, Injection site swelling, Pain
Clinical narrative: Patient recieved Injection at 2PM in the afternoon on 3/10/08 in his left Deltoid muscle. He stated to me that from the time he recieved the injection the area started to hurt and by that evening his arm started to swell from his elbow to the top of his shoulder. He stated that he could not lift his arm it was too painful. The area was swollen and painful. It kept him up all night, he also stated he had body aches with it. The symptoms lasted 2 days. He didn't report it until the third day by then the area was much better but you could see the outline of where the redness had been. He stated three of Dr.'s staff saw his arm. He had used ice to the site to relieve the swelling and pain.
Age: 76.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Erythema, Injection site pain, Injection site swelling, Insomnia, Pain
Clinical narrative: Patient recieved Injection at 2PM in the afternoon on 3/10/08 in his left Deltoid muscle. He stated to me that from the time he recieved the injection the area started to hurt and by that evening his arm started to swell from his elbow to the top of his shoulder. He stated that he could not lift his arm it was too painful. The area was swollen and painful. It kept him up all night, he also stated he had body aches with it. The symptoms lasted 2 days. He didn't report it until the third day by then the area was much better but you could see the outline of where the redness had been. He stated three of Dr.'s staff saw his arm. He had used ice to the site to relieve the swelling and pain.
Age: 0.17
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Crying, Immediate post-injection reaction, Pain, Vomiting projectile
Clinical narrative: Infant given Rotateq before other vaccinations administered.  Rotateq given orally over about 45 seconds.  Infant calm and quiet.  Infant had projectile vomiting within 20 seconds of completion of Rotateq vaccine.  After initial vomitus infant crying, and was inconsolable even by mom and dad.  Infant appeared to be in pain.  Infant then had another episode of projectile vomiting.  Infant still appeared to be in pain and continued to cry inconsolably for about 15 minutes after final vomitus.  After waiting for five minutes final vaccinations given. Infant finally able to be consoled by parents.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Induration
Clinical narrative: 12 CM BY 10 CM REDNESS AND INDURATION OF LEFT DELTOID
Age: 14.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria
Clinical narrative: Vaccine was given on 2/13/08. The next a.m. (2/14/08) injection site was itching, red, and swollen. An approximate 4cm whelp at injection site noted, with swelling to left upper arm. 2/15 mother reports area remains swollen and itching at injection site. 2/17 symptoms improving and subsiding. Advised parent to see physician. Treated at home with cold compress, Benadryl and ibuprofen.
Age: 28.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Body temperature increased, Dizziness, Heart rate increased, Injection site pruritus, Injection site rash
Clinical narrative: FEVER OF 101.5, HEART RATE OF 110 BPM (PATIENT NORMAL HEART RATE 80-85 BPM)- DEVELOPED 48 HOURS AFTER VACCINE ADMINISTRATION, SWELLING/RASH WHERE PATIENT RECEIVED VACCINE, ITCHING WHERE PATIENT RECEIVED VACCINE - DEVELOPED SAME DAY OF VACCINE ADMINISTRATION - NO TREATMENT FOR ADVERSE EVENTS HAVE BEEN ADMINISTERED AS OF THIS TIME
Age: 28.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: FEVER OF 101.5, HEART RATE OF 110 BPM (PATIENT NORMAL HEART RATE 80-85 BPM)- DEVELOPED 48 HOURS AFTER VACCINE ADMINISTRATION, SWELLING/RASH WHERE PATIENT RECEIVED VACCINE, ITCHING WHERE PATIENT RECEIVED VACCINE - DEVELOPED SAME DAY OF VACCINE ADMINISTRATION - NO TREATMENT FOR ADVERSE EVENTS HAVE BEEN ADMINISTERED AS OF THIS TIME
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Abasia, Amnesia, Biopsy heart, Cardiac arrest, Electrocardiogram
Clinical narrative: Cardiac arrest, no pulse, clinically dead, for several minutes until EMT arrived and used defibrillator paddles to re start heart.  Ambulance to Hospital for about 4 to 5 hours.  Transported by ambulance to facility.  Unconscious for 2 days sedated.  After she awoke she was unresponsive to family and friends, impaired speech, memory loss and no ability to walk for about 10 days.  The first night the many test were run and continued through 29 day stay at the hospital.  Treatment included pills, physical therapy, stress testing, 24 hour monitoring of heart and attendant care.  EKG, Biopsy of heart, injection of dye to heart, MRI of Brain and Heart.  A permanent defibrillator connecting to the heart. 05/05/08-DC summary received for DOS 10/18/11/13/07-DC DX: Ventricular fibrillation, cardiac Arrest. Placement of cardiac defibrillator (internal), pacemaker generator and lead system.  4/24/08-records received-10/18/07-presented to ED with cardiac arrest, ventricular fibrillation. Playing basketball, suddenly had shaking of right arm and deep breaths. Fell down. CPR began, cardioversion successful. Never fully regained consciousness. Respiratory failure. Intubated on ventilator. Extubated. Fentanyl drip. Hypertension since arrival.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Implantable defibrillator insertion, Loss of consciousness, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain, Pulse absent
Clinical narrative: Cardiac arrest, no pulse, clinically dead, for several minutes until EMT arrived and used defibrillator paddles to re start heart.  Ambulance to Hospital for about 4 to 5 hours.  Transported by ambulance to facility.  Unconscious for 2 days sedated.  After she awoke she was unresponsive to family and friends, impaired speech, memory loss and no ability to walk for about 10 days.  The first night the many test were run and continued through 29 day stay at the hospital.  Treatment included pills, physical therapy, stress testing, 24 hour monitoring of heart and attendant care.  EKG, Biopsy of heart, injection of dye to heart, MRI of Brain and Heart.  A permanent defibrillator connecting to the heart. 05/05/08-DC summary received for DOS 10/18/11/13/07-DC DX: Ventricular fibrillation, cardiac Arrest. Placement of cardiac defibrillator (internal), pacemaker generator and lead system.  4/24/08-records received-10/18/07-presented to ED with cardiac arrest, ventricular fibrillation. Playing basketball, suddenly had shaking of right arm and deep breaths. Fell down. CPR began, cardioversion successful. Never fully regained consciousness. Respiratory failure. Intubated on ventilator. Extubated. Fentanyl drip. Hypertension since arrival.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Speech disorder, Unresponsive to stimuli
Clinical narrative: Cardiac arrest, no pulse, clinically dead, for several minutes until EMT arrived and used defibrillator paddles to re start heart.  Ambulance to Hospital for about 4 to 5 hours.  Transported by ambulance to facility.  Unconscious for 2 days sedated.  After she awoke she was unresponsive to family and friends, impaired speech, memory loss and no ability to walk for about 10 days.  The first night the many test were run and continued through 29 day stay at the hospital.  Treatment included pills, physical therapy, stress testing, 24 hour monitoring of heart and attendant care.  EKG, Biopsy of heart, injection of dye to heart, MRI of Brain and Heart.  A permanent defibrillator connecting to the heart. 05/05/08-DC summary received for DOS 10/18/11/13/07-DC DX: Ventricular fibrillation, cardiac Arrest. Placement of cardiac defibrillator (internal), pacemaker generator and lead system.  4/24/08-records received-10/18/07-presented to ED with cardiac arrest, ventricular fibrillation. Playing basketball, suddenly had shaking of right arm and deep breaths. Fell down. CPR began, cardioversion successful. Never fully regained consciousness. Respiratory failure. Intubated on ventilator. Extubated. Fentanyl drip. Hypertension since arrival.
Age: 58.0
Sex: M
Vaccine: HEPA
Symptoms: Diarrhoea, Malaise, Pruritus, Rash
Clinical narrative: Has had diarrhea since 2 days after taking the shot. Some itching/a few bumps here/there on body. Overall feeling of not well.
Age: 32.0
Sex: F
Vaccine: HEPA
Symptoms: Pruritus, Rash vesicular
Clinical narrative: Broke out with strange bumps with designs and similar to chicken pox. She went to emergency room and they said they never seen anything like it. Dr gave her prescription for (PACK) and she went to dermatologist and he gave her some cream. Nothing has helped. She is still breaking out. She itches.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Gaze palsy, Mydriasis, Syncope
Clinical narrative: Within a minute of Gardasil Vaccine she fainted with eyes open and dilated at full extend, started convulsing for 5 seconds, eyes started to shake also.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Eye swelling, Hypersensitivity, Throat tightness
Clinical narrative: Mother of client called and reported "she had an allergic reaction. Her eyes swelled and her throat was closing up". Reports client took Benadryl, but had to go to clinic for treatment. States "She's ok now".
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Dyspnoea, Pharyngeal oedema, Rash, Urticaria
Clinical narrative: Approximately 20-30 minutes after vaccine given pt c/o dizziness, throat swelling, hard to breath. Had hives/rash on head, neck and upper chest.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Induration, Nausea, Pain, Pyrexia
Clinical narrative: 2 hours s/p Adacel injection (L) deltoid, pt experienced pain/swelling/erythema, nausea and subjective fevers. Seen by me 2 day s/p injection. 7x4 cm erythema with induration - severely tender to palp.
Age: 29.0
Sex: F
Vaccine: TDAP
Symptoms: Swelling, Tenderness
Clinical narrative: 2 hours s/p Adacel injection (L) deltoid, pt experienced pain/swelling/erythema, nausea and subjective fevers. Seen by me 2 day s/p injection. 7x4 cm erythema with induration - severely tender to palp.
Age: 35.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Blood culture negative, Pyrexia, Ultrasound scan normal
Clinical narrative: Pt developed fever to 103 day after vaccine.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain upper, Anorexia, Condition aggravated, Diarrhoea, Hypersensitivity
Clinical narrative: Stomach problems, loss of appetite, upset stomach progressed to pain in stomach, ankle stiffer, nausea, diarrhea, allergies more prominent.  3/20 visited doctor for stomach problems, given Sucralsate and another over the counter medicine.  Today took medicine.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Joint stiffness, Nausea, Stomach discomfort
Clinical narrative: Stomach problems, loss of appetite, upset stomach progressed to pain in stomach, ankle stiffer, nausea, diarrhea, allergies more prominent.  3/20 visited doctor for stomach problems, given Sucralsate and another over the counter medicine.  Today took medicine.
Sex: U
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pain, Pyrexia, Swelling
Clinical narrative: Rapid onset of swelling and pain within 12 hours followed by fever. About 3x4 in area of swelling; Left Deltoid
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Erythema, Swelling, Urticaria
Clinical narrative: (L) thigh 2x3 raised red welt thigh slight increase in size, site not painful to palpation, no blister, no d/c
Age: 0.3
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Convulsion, Full blood count, Physical examination
Clinical narrative: Likely seizure-taken to ER and less responsive. Examined and observed. No more seizure.
Age: 4.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Chills, Generalised erythema, Pruritus, Urticaria, Vomiting
Clinical narrative: 4 year old male received booster MMR at 11:30AM 3/27/08.  Within 10 minutes he had multiple episodes of vomiting, followed by generalized erythema, urticarial hives and pruritis.  Thereafter, he developed chills.  He was given Antihistamine with no improvement followed 45 minutes later by doctor.  He improved within 1 hour.
Age: 4.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Abdominal pain, Erythema, No reaction on previous exposure to drug, Pruritus, Vomiting
Clinical narrative: 4 year old male received booster MMR at 11:30AM 3/27/08.  Within 10 minutes he had multiple episodes of vomiting, followed by generalized erythema, urticarial hives and pruritis.  Thereafter, he developed chills.  He was given Antihistamine with no improvement followed 45 minutes later by doctor.  He improved within 1 hour.
Age: 1.6
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Skin warm
Clinical narrative: 7-8 cm round, red, warm left anterior thigh.  No streaking.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Blood lead increased, Full blood count, Lymphocyte count increased, Platelet count decreased, Pyrexia
Clinical narrative: Pt received immunizations on Monday 3-24-08; woke up 6:30 am, Tuesday (3-25) with 101 deg fever. Rash started Wednesday (3-26) evening, worse today (3-27). Rash on hands, feet, face. No respiratory problems. Vital signs today (3-27) Temp 97.5 tympanic. No wheezing, no SOB Rash urticarial.
Age: 2.0
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Rash, White blood cell count increased
Clinical narrative: Pt received immunizations on Monday 3-24-08; woke up 6:30 am, Tuesday (3-25) with 101 deg fever. Rash started Wednesday (3-26) evening, worse today (3-27). Rash on hands, feet, face. No respiratory problems. Vital signs today (3-27) Temp 97.5 tympanic. No wheezing, no SOB Rash urticarial.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Erythema, Oedema peripheral, Pruritus, Skin warm
Clinical narrative: Warm, red and swollen on (L) thigh Itchy pt. scratching
Age: 8.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Fatigue, Inflammation, Oedema peripheral
Clinical narrative: Within 1 day of receiving Varicella, childs arm became puffy and inflamed 1" x 1" at inj. site. No fever just "a little tired; however child is playing eating and active.
Age: 11.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Injection site inflammation
Clinical narrative: Within 1 day of receiving Varicella inj site became slightly inflamed. Mom estimates approx 1.5" x 1.5 ". No fever or malaise reported.
Age: 27.0
Sex: F
Vaccine: FLUX
Symptoms: Chest discomfort, Dizziness, Oesophageal stenosis, Panic attack
Clinical narrative: This case was reported by a pharmacist and described the occurrence of chest heaviness in a 27-year-old female subject who was vaccinated with influenza virus vaccine (manufacturer unspecified). The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject had no prior vaccination with influenza virus vaccine. On 20 November 2007 the subject received 1st dose of Influenza virus vaccine (unknown). On 21 November 2007, 1 day after vaccination with Influenza virus vaccine, the subject experienced chest heaviness, panic attack and feeling of esophagus closing (described as pressure felt on the esophagus). At the time of receipt of influenza virus vaccine, the subject was breast feeding a child who was born in June 2007. No other details regarding the neonate were provided. The subject was seen at a physician's office. At the time of reporting the events were worse.  Follow-up information on 17 December 2007 indicated that the events actually occurred on the same day of vaccination, 20 November 2007. Light headedness was reported as an additional event also beginning the same day of vaccination, 20 November 2007. The events were all resolved and indicated as possibly related to influenza virus vaccine.